# Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

> **NCT04061746** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells (MSCs)
- **OTHER:** Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)

## Key facts

- **NCT ID:** NCT04061746
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-27
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061746, "Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04061746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*